Nan Zhang

This record appears to aggregate work spanning a wide range of medical topics, including liver and gallbladder cancers, cardiovascular disease, diabetes, breast cancer, and gut microbiome research, often using methods like deep learning image analysis, single-cell sequencing, and large-scale retrospective or meta-analysis studies. The breadth of topics and very low co-author overlap suggest this name may represent multiple contributors or a broad clinical research collaboration rather than a single tightly focused lab. Prospective students should note the diversity of subject areas covered under this name, from oncology treatment outcomes to environmental groundwater remediation.

Publication output has grown substantially over the last decade, rising from around 14 papers per year in 2017 to a peak near 40 in 2024, with a slight decline in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026